A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancer
Phase 1
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000022082
- Lead Sponsor
- Yamaguchi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Uncontroled general complication. etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method 1)specific CTL response 2)overall survival 3)progression-free survival 4)Response rate 5)disease control rate